by Suzanne Gaunt | Jun 10, 2025 | Long Covid
The Immune Response to SARS-CoV-2 and Long COVID Long COVID is currently reported to affect as many as one in five individuals who have had a COVID infection in the UK, with each new SARS-CoV-2 infection adding to the risk burden of developing the debilitating...
by Suzanne Gaunt | Apr 9, 2025 | Long Covid
EXETER, UK – 4 April 2025 – Attomarker, a leader in rapid diagnostic technology, today announced its plans for a new study evaluating the use of AstraZeneca’s monoclonal antibody, Sipavibart (Kavigale), as a potential treatment for long COVID patients. Long COVID...
by Suzanne Gaunt | Mar 13, 2025 | Long Covid
International Long COVID Awareness Day 2025 Five Years On, Long COVID Patients Are Still Being Left Behind On 15th March we mark five years since the start of the pandemic and with it, International Long COVID Awareness Day. While COVID-19 may have faded from...
by Jonathan | Jun 6, 2024 | Long Covid
A Novel Diagnosis and Treatment TO BOOK YOUR ANTIBODY IMMUNITY SPECTRUM TEST: Visit our clinics Elimination of a SARS-CoV-2 infection requires both antibody and T cells for complete clearance of the coronavirus from the localised infection site. Systemic...
by Jas Emmerson | May 18, 2023 | Long Covid
A Novel Diagnosis and Treatment TO BOOK YOUR ANTIBODY IMMUNITY SPECTRUM TEST: longcovid@re-cognitionhealth.comElimination of a SARS-CoV-2 infection requires both antibody and T cells for complete clearance of the coronavirus from the localised infection site. Systemic...
by admin | May 4, 2023 | Long Covid, Scientific Announcements
#LongCovid is now affecting over 2 million people in the UK, a “mass disabling event” harming health and livelihoods. In the US, where it is reported over 20 million are afflicted with the condition, Long Covid is being described as the “next public health...
